Yüklüyor......
Neuroprotective therapies for glaucoma
Glaucoma is the second leading cause for blindness worldwide. It is mainly caused by glaucomatous optic neuropathy (GON) characterized by retinal ganglion cell loss, which leads to visual field defect and blindness. Up to now, the main purpose of antiglaucomatous therapies has been to lower intraocu...
Kaydedildi:
| Yayımlandı: | Drug Des Devel Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362661/ https://ncbi.nlm.nih.gov/pubmed/25792807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S80594 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|